ISSUE 5 of 6 - In Vitro Diagnostics Business Outlook: Focus on Continuous Glucose Monitoring (CGM)
Description
The in vitro diagnostics (IVD) sector stands as a cornerstone of modern healthcare, empowering clinicians with the tools to detect diseases, monitor health conditions, and guide precise treatment decisions.
As healthcare evolves, the IVD market is poised for transformative growth. With the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases, as well as ongoing threats from infectious diseases like COVID-19 and emerging variants, the demand for innovative diagnostic solutions has never been greater.
In Vitro Diagnostics Business Outlook is a bimonthly publication, delivering six issues annually, each dedicated to a different segment of the IVD industry. It provides exclusive insights and data, including:
As healthcare evolves, the IVD market is poised for transformative growth. With the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases, as well as ongoing threats from infectious diseases like COVID-19 and emerging variants, the demand for innovative diagnostic solutions has never been greater.
In Vitro Diagnostics Business Outlook is a bimonthly publication, delivering six issues annually, each dedicated to a different segment of the IVD industry. It provides exclusive insights and data, including:
- Market Data and Forecasts: Detailed growth rates, market size, and market share to identify new opportunities.
- Comprehensive Market View: Coverage of test categories and company profiles.
- M&A Activities: Updates on mergers, acquisitions, partnerships, and collaborations.
- Industry & Region Watch: Tailored strategies based on regional and industry-specific trends.
- News Analysis: In-depth reporting on significant news and events, including exclusive information not readily available elsewhere.
Table of Contents
49 Pages
- Overview of Continuous Glucose Monitoring
- Overview of Continuous Glucose Monitoring
- Regional Market
- Company Briefs
- Rapidemic Secures €2.3 Million Grant
- StratifAI Secures €12.5 Million for Precision Oncology
- Predicta Biosciences Raises $23.4 Million in Series A Funding
- Predicta Biosciences Welcomes New CEO
- Owlstone Medical Scores $49.1 million
- Fulgent Genetics Posts Strong Performance in Core Revenue
- Thermo Fisher Maintains Steady Performance in H1 2025
- Partnerships and Collaborations
- Industry Watch COVID-19/Flu Update
- Belgium
- Guardant Health Secures FDA Nod for CDx
- ClearNote Health Receives UKCA Approval for Two Early Detection Cancer Tests
- Xpedite Dx Launches One-Step Viral DNA/RNA Extraction Kit
- NeuroKaire Launches Unique Test for MDD
- Mirxes Gains NMPA Approval
- CND Life Sciences Scores FDA Breakthrough Device Designation
- Hologic Gains FDA and CE Mark for Molecular Tests
- J&J Intends to Spin Off Orthopedic Business
- Roche Receives Go-Ahead From FDA
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



